Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

Biodesix (BDSX) Accumulated Depreciation & Amortization: 2019-2025

Historic Accumulated Depreciation & Amortization for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $11.7 million.

  • Biodesix's Accumulated Depreciation & Amortization rose 41.98% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.7 million, marking a year-over-year increase of 50.91%. This contributed to the annual value of $9.1 million for FY2024, which is 62.76% up from last year.
  • Latest data reveals that Biodesix reported Accumulated Depreciation & Amortization of $11.7 million as of Q3 2025, which was up 8.29% from $10.8 million recorded in Q2 2025.
  • Biodesix's Accumulated Depreciation & Amortization's 5-year high stood at $11.7 million during Q3 2025, with a 5-year trough of $5.6 million in Q4 2023.
  • For the 3-year period, Biodesix's Accumulated Depreciation & Amortization averaged around $8.4 million, with its median value being $7.9 million (2023).
  • In the last 5 years, Biodesix's Accumulated Depreciation & Amortization fell by 20.03% in 2023 and then spiked by 62.76% in 2024.
  • Over the past 5 years, Biodesix's Accumulated Depreciation & Amortization (Quarterly) stood at $6.7 million in 2021, then grew by 3.99% to $7.0 million in 2022, then decreased by 20.03% to $5.6 million in 2023, then soared by 62.76% to $9.1 million in 2024, then spiked by 41.98% to $11.7 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $11.7 million for Q3 2025, versus $10.8 million for Q2 2025 and $10.1 million for Q1 2025.